1. Dolutegravir-based antiretroviral therapy regimens effectively suppressed maternal viral load during pregnancy, supporting their use to prevent vertical transmission.
2. Dolutegravir, emtricitabine, and tenofovir alafenamide fumarate carried relatively low risk of adverse fetal outcomes.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Initiation of antiretroviral therapy (ART) for pregnant women infected with HIV-1...